A novel mouse model for inhibition of DOHH-mediated hypusine modification reveals a crucial function in embryonic

Henning Sievert1, Nora Pällmann2, Katharine K Miller3

  • 1Department of Oncology, Hematology and Bone Marrow Transplantation with Section Pneumology, Hubertus Wald-Tumor Zentrum, University Hospital Eppendorf, 20246 Hamburg, Germany.

Insights

The DOHH enzyme

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Genetics

Background:

  • Post-translational modification regulates translation, impacting protein synthesis and cellular proliferation.
  • Hypusination of eukaryotic initiation factor 5A (eIF5A) is a unique regulatory pathway.
  • The precise physiological roles of hypusination, particularly the second step, remain largely unknown.

Purpose of the Study:

  • To investigate the evolutionary conserved role of the DOHH-mediated second step of hypusine synthesis.
  • To elucidate the cellular and physiological consequences of DOHH deletion.
  • To establish a conditional mouse model for studying hypusination in vivo.

Main Methods:

  • Generation and utilization of conditional knockout mouse and Caenorhabditis elegans models.
  • Cellular proliferation and senescence assays in 3T3 Dohh-/- cells.
  • Mass spectrometry to analyze hypusine modification levels.

Main Results:

  • DOHH plays a conserved role in early embryonic development.
  • DOHH deletion leads to reduced cellular proliferation, induced senescence, and impaired malignant transformation.
  • Complete loss of hypusine modification was observed upon DOHH deletion.
  • The conditional mouse model allows for temporal and spatial manipulation of hypusination.

Conclusions:

  • The second step of hypusination, mediated by DOHH, is crucial for normal embryonic development and cellular homeostasis.
  • DOHH is essential for eIF5A hypusination, impacting protein synthesis and cell proliferation.
  • The developed mouse model is a valuable tool for future research into hypusination's role in health and disease.